Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Organogenesis Holdings (ORGO) EPS (Basic) (2017 - 2025)

Historic EPS (Basic) for Organogenesis Holdings (ORGO) over the last 9 years, with Q3 2025 value amounting to $0.11.

  • Organogenesis Holdings' EPS (Basic) rose 2222.22% to $0.11 in Q3 2025 from the same period last year, while for Sep 2025 it was -$0.12, marking a year-over-year decrease of 10000.0%. This contributed to the annual value of -$0.01 for FY2024, which is 11779.02% down from last year.
  • Latest data reveals that Organogenesis Holdings reported EPS (Basic) of $0.11 as of Q3 2025, which was up 2222.22% from -$0.1 recorded in Q2 2025.
  • In the past 5 years, Organogenesis Holdings' EPS (Basic) registered a high of $0.39 during Q4 2021, and its lowest value of -$0.17 during Q1 2025.
  • For the 5-year period, Organogenesis Holdings' EPS (Basic) averaged around $0.04, with its median value being $0.04 (2023).
  • In the last 5 years, Organogenesis Holdings' EPS (Basic) soared by 113085.93% in 2024 and then plummeted by 75000.0% in 2025.
  • Over the past 5 years, Organogenesis Holdings' EPS (Basic) (Quarter) stood at $0.39 in 2021, then tumbled by 84.62% to $0.06 in 2022, then crashed by 107.21% to -$0.0 in 2023, then surged by 1130.86% to $0.04 in 2024, then surged by 146.54% to $0.11 in 2025.
  • Its last three reported values are $0.11 in Q3 2025, -$0.1 for Q2 2025, and -$0.17 during Q1 2025.